Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Control Bionics Limited has requested a trading halt for its securities pending an announcement regarding a proposed placement and rights issue. The halt will remain in effect until the commencement of normal trading on a specified date or until the announcement is released. The company believes that the market may not be properly informed about the proposed placement.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-1275
In the deck
Earlier from Control Bionics
- Exclusive UK and Ireland Distribution Agreement
- New US Insurance Code Approved
- Share placement - North Star Impact Fund to invest
- TGA Approval Granted for DROVE Autonomous Wheelchair Module
- Control Bionics completes successful $1.04m placement
Later from Control Bionics
- Investor Presentation
- Non-Renounceable Issue
- Non-renounceable rights issue offer and private placement ad
- Placement
- Addendum to notice of 2024 AGM
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics